CELZ — Creative Medical Technology Holdings, Inc.
Creative Medical Technology Holdings, Inc., a biotechnology firm based in Phoenix, Arizona, specializes in advancing adult stem cell treatments. The company's core focus spans several medical fields, including immunology, urology, orthopedics, and neurology. Among its therapeutic offerings are CaverStem, designed to address erectile dysfunction; FemCelz, which aims to restore genital sensitivity and alleviate dryness; StemSpine, developed to treat chronic lower back pain; ImmCelz, intended for stroke patients; and OvaStem, a solution for female infertility.
Company profile
- Sector: Healthcare
- Industry: Biotechnology
- Country: US
- Exchange: NASDAQ Capital Market
- Employees: 4
- Website: https://www.creativemedicaltechnology.com
Latest SEC filings for CELZ
- 8-K — 2026-08-31
- 10-Q — 2026-08-07
- 424B3 — 2026-08-03
- S-3 — 2026-07-24
- S-3 — 2026-07-24
- 8-K — 2026-07-02
- RW — 2026-06-30
- S-1/A — 2026-06-26
- S-1/A — 2026-06-26
- S-1 — 2026-06-25
Latest CELZ news
- — Head to Head Analysis: Creative Medical Technology (NASDAQ:CELZ) versus Grifols (NASDAQ:GRFS) (defenseworld.net)
Educational tool only — not investment advice.